Ricerca avanzata

Home > Riviste > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Fascicoli precedenti > The Quarterly Journal of Nuclear Medicine 2003 Giugno;47(2)

FASCICOLI E ARTICOLI   I PIÙ LETTI   eTOC

ULTIMO FASCICOLOTHE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Rivista di Medicina Nucleare e Imaging Molecolare

A Journal on Nuclear Medicine and Molecular Imaging
Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 2,413

Periodicità: Trimestrale

ISSN 1824-4785

Online ISSN 1827-1936

 

The Quarterly Journal of Nuclear Medicine 2003 Giugno;47(2)

 ORIGINAL ARTICLES

The Quarterly Journal of Nuclear Medicine 2003 Giugno;47(2):77-84

Advanced ovarian carcinoma: usefulness of [18F]FDG-PET in combination with CT for lesion detection after primary treatment

Picchio M., Sironi S., Messa C., Mangili G., Landoni C., Gianolli L., Zangheri B., Viganò R., Aletti G. De Marzi P., De Cobelli F., Del Maschio A., Ferrari A., Fazio F.


The Quarterly Journal of Nuclear Medicine 2003 Giugno;47(2):85-9

Paraneoplastic syndromes: detection of malignant tumors using [18F]FDG-PET

Berner U., Menzel C., Rinne D., Kriener S., Hamscho N., Döbert N., Diehl M., Kaufmann R., Grünwald F.


The Quarterly Journal of Nuclear Medicine 2003 Giugno;47(2):90-100

Evaluation of the clinical performances of a large NaI(Tl) crystal 3D PET scanner

Picchio M., Savi A., Lecchi M., Landoni C., Gianolli L., Brioschi M., Rossetti C., Gilardi M. C., Fazio F.


The Quarterly Journal of Nuclear Medicine 2003 Giugno;47(2):101-8

Hodgkin’s disease. Prognostic value of Gallium-67 scintigraphy

Hervás I., Segura A., López-Tendero P., Bello P., González-Cabezas P., Flores D., Yuste A., Pérez-Velasco R., Girones R., Mateo A.


The Quarterly Journal of Nuclear Medicine 2003 Giugno;47(2):109-15

Is there a role for 99mTc-anti-CEA monoclonal antibody imaging in the diagnosis of recurrent colorectal carcinoma?

Fuster D., Maurel J., Muxí A., Setoain X., Ayuso C., Martín F., Ortega M. L., Fuertes S., Pons F.


The Quarterly Journal of Nuclear Medicine 2003 Giugno;47(2):116-28

The role of 99mTc-tetrofosmin pinhole-SPECT in breast cancer non palpable axillary lymph node metastases detection

Spanu A., Tanda F., Dettori G., Manca A., Chessa F., Porcu A., Falchi A., Nuvoli S., Madeddu G.


The Quarterly Journal of Nuclear Medicine 2003 Giugno;47(2):129-38

Importance of radio-guided minimally invasive parathyroidectomy using hand-held γ probe and low 99mTc-MIBI dose. Technical considerations and long-term clinical results

Rubello D., Casara D., Giannini S., Piotto A., De Carlo E., Muzzio P. C., Pelizzo M. R.


The Quarterly Journal of Nuclear Medicine 2003 Giugno;47(2):139-44

Radioimmuno targetting technetium 99mlabeled anti-epidermal growth factor receptor monoclonal antibody in experimental tumor models

Meenakshi A., Ganesh V., Suresh Kumar R., Siva Kumar N.


inizio pagina